Results 11 to 20 of about 176,829 (191)
Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
Neonatology, 2021 Bronchopulmonary dysplasia (BPD) remains a major morbidity for infants born preterm. Postnatal corticosteroids might reduce the risk of developing BPD, or reduce its severity when it occurs, because of their powerful anti-inflammatory effects.
L. Doyle
semanticscholar +1 more source
Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia
Journal of Perinatology, 2021 Bronchopulmonary dysplasia (BPD) is a chronic lung disease commonly affecting extremely preterm infants. Although mechanical ventilation and oxygen requirements in premature infants are identified as inciting mechanisms for inflammation and the ...
Zeyar T. Htun +7 more
semanticscholar +1 more source
Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies
Disease Models & Mechanisms, 2021 Bronchopulmonary dysplasia (BPD) is a chronic lung disease caused by exposure to high levels of oxygen (hyperoxia) and is the most common complication that affects preterm newborns. At present, there is no cure for BPD.
Kiersten Giusto +3 more
semanticscholar +1 more source
Lung growth and pulmonary function after prematurity and bronchopulmonary dysplasia
Pediatric Pulmonology, 2021 Bronchopulmonary dysplasia (BPD) still carries a heavy burden of morbidity and mortality in survivors of extreme prematurity. The disease is characterized by simplification of the alveolar structure, involving a smaller number of enlarged alveoli due to ...
Laura Moschino +2 more
semanticscholar +1 more source
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
American Journal of Respiratory and Critical Care Medicine, 2019 Rationale: Current diagnostic criteria for bronchopulmonary dysplasia rely heavily on the level and duration of oxygen therapy, do not reflect contemporary neonatal care, and do not adequately predict childhood morbidity.
E. Jensen +12 more
semanticscholar +1 more source
American Journal of Respiratory and Critical Care Medicine, 2020 RATIONALE Bronchopulmonary dysplasia (BPD) is a heterogenous condition with poorly characterized disease subgroups. OBJECTIVES To define the frequency of three disease components: moderate-severe parenchymal disease, pulmonary hypertension (PH), or ...
Katherine Wu +9 more
semanticscholar +1 more source
Association Between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants.
American Journal of Respiratory and Critical Care Medicine, 2021 RATIONALE Bronchopulmonary dysplasia increases the risk of disability in extremely preterm infants. Although the pathophysiology remains uncertain, prior exposure to intermittent hypoxemia may play a role in this relationship.
E. Jensen +5 more
semanticscholar +1 more source
Pulmonary hypertension in bronchopulmonary dysplasia
Pediatric Research, 2020 Bronchopulmonary dysplasia (BPD) is a major complication in prematurely born infants. Pulmonary hypertension (PH) associated with BPD (BPD-PH) is characterized by alveolar diffusion impairment, abnormal vascular remodeling, and rarefication of pulmonary ...
G. Hansmann +5 more
semanticscholar +1 more source
Pulmonary hypertension in the child with bronchopulmonary dysplasia
Pediatric Pulmonology, 2021 Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease of prematurity resulting from complex interactions of perinatal factors that often lead to prolonged respiratory support and increased pulmonary morbidity.
K. W. Malloy, E. Austin
semanticscholar +1 more source
Present and Future of Bronchopulmonary Dysplasia
Journal of Clinical Medicine, 2020 Bronchopulmonary dysplasia (BPD) is the most common respiratory disorder among infants born extremely preterm. The pathogenesis of BPD involves multiple prenatal and postnatal mechanisms affecting the development of a very immature lung.
Luca Bonadies +5 more
semanticscholar +1 more source